Omeros Corp. (OMER)
19.82
+0.70
(+3.69%)
USD |
NASDAQ |
Oct 09, 16:00
19.82
0.00 (0.00%)
After-Hours: 20:00
Omeros Enterprise Value : 1.543B for Oct. 8, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.543B |
| October 07, 2026 | 1.517B |
| October 06, 2026 | 1.499B |
| October 05, 2026 | 1.527B |
| October 02, 2026 | 1.506B |
| October 01, 2026 | 1.496B |
| September 30, 2026 | 1.537B |
| September 29, 2026 | 1.553B |
| September 28, 2026 | 1.566B |
| September 25, 2026 | 1.612B |
| September 24, 2026 | 1.616B |
| September 23, 2026 | 1.660B |
| September 22, 2026 | 1.682B |
| September 21, 2026 | 1.498B |
| September 18, 2026 | 1.453B |
| September 17, 2026 | 1.495B |
| September 16, 2026 | 1.415B |
| September 15, 2026 | 1.403B |
| September 14, 2026 | 1.424B |
| September 11, 2026 | 1.483B |
| September 10, 2026 | 1.505B |
| September 09, 2026 | 1.563B |
| September 08, 2026 | 1.543B |
| September 04, 2026 | 1.531B |
| September 03, 2026 | 1.543B |
| Date | Value |
|---|---|
| September 02, 2026 | 1.524B |
| September 01, 2026 | 1.517B |
| August 31, 2026 | 1.519B |
| August 28, 2026 | 1.506B |
| August 27, 2026 | 1.553B |
| August 26, 2026 | 1.478B |
| August 25, 2026 | 1.555B |
| August 24, 2026 | 1.558B |
| August 21, 2026 | 1.554B |
| August 20, 2026 | 1.508B |
| August 19, 2026 | 1.491B |
| August 18, 2026 | 1.404B |
| August 17, 2026 | 1.416B |
| August 14, 2026 | 1.404B |
| August 13, 2026 | 1.416B |
| August 12, 2026 | 1.153B |
| August 11, 2026 | 1.145B |
| August 10, 2026 | 1.147B |
| August 07, 2026 | 1.120B |
| August 06, 2026 | 1.113B |
| August 05, 2026 | 1.077B |
| August 04, 2026 | 1.098B |
| August 03, 2026 | 1.070B |
| July 31, 2026 | 1.018B |
| July 30, 2026 | 1.025B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Eli Lilly & Co. | 1.147T |
| Talphera, Inc. | 45.48M |
| Jaguar Health, Inc. | 11.49M |
| Hyperion DeFi, Inc. | 50.76M |
| Structure Therapeutics, Inc. | 491.70M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 6.637M |
| Revenue (Quarterly) | 28.53M |
| Total Expenses (Quarterly) | 21.89M |
| EPS Diluted (Quarterly) | 0.1476 |
| Gross Profit Margin (Quarterly) | 96.50% |
| Profit Margin (Quarterly) | 23.26% |
| Earnings Yield | 7.25% |
| Normalized Earnings Yield | 8.503 |